DiagnOptics offers non-invasive and immediate assesment of cardiovascular risk and risk of diabetes with the AGE Reader (cardiovascular risk) and Diab-spot (diabetes screening).
To familiarize physicians with medical benefits of the Transcendental Meditation (TM) technique and research on health applications, with emphasis on cardiovascular disease, risk factors, stress, hypertension, and overall health.
The Morris Cardiovascular and Risk Reduction Center is a comprehensive facility that offers individualized care for each patient while taking a unique approach to heart disease. Our goal is to improve the health and quality of life in our community.
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Seven Countries Study started in 1958 and was the first nutrition study to investigate the association between cholesterol (and other risk factors) and coronary heart disease (CHD).
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C
The Seven Countries Study started in 1958 and was the first nutrition study to investigate the association between cholesterol (and other risk factors) and coronary heart disease (CHD).
The Cardiometabolic Health Congress (CMHC) is a comprehensive medical education meeting on cardiometabolic risk that provides clinicians with the tools and treatment strategies to appropriately diagnose, treat, and reduce CVD. The Cardiometabolic Health C